

HY-P99517 · 1 mg
MedChemExpress · Cat: HY-P99517
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/voxalatamab.html
Description
Voxalatamab JNJ-63898081 is a bispecific IgG4 antibody targeting PSMA and CD3. Voxalatamab attacks PSMA-expressing tumor cells by activating T cells. Voxalatamab has anticancer activity and is being studied for the treatment of solid tumors such as prostate cancer.







